Characterization of Human Olfactory Amygdala Subregions exp2
Northwestern University · NCT07074574
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 1
- Study start
- January 1, 2022
- Record last updated
- May 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
We aim to better understand the functions of the subregions of the human amygdala that receive direct projections from the olfactory bulb
Being studied: Present odors to participants while recording brain activity using fMRI
Conditions: Changes in Olfactory Behavior Across Different Contexts Associated With Different Amygdala Subregions
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- older than 18 years of age
Exclusion Criteria
-
Recruiting US locations
Northwestern human olfaction lab
Chicago, IL 60611
Site contact: Research Study Assistant · 3125034437
Study contacts (from the official record)
- Christina Zelano, PhD · 312-503-4437 · c-zelano@northwestern.edu
- Gregory Lane · 312-503-4437 · lane@northwestern.edu
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65